» Articles » PMID: 22230295

Cocaine Use During Pregnancy Assessed by Hair Analysis in a Canary Islands Cohort

Overview
Publisher Biomed Central
Date 2012 Jan 11
PMID 22230295
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Drug use during pregnancy is difficult to ascertain, and maternal reports are likely to be inaccurate. The aim of this study was to estimate the prevalence of illicit drug use among pregnant women by using maternal hair analysis.

Methods: A toxicological analysis of hair was used to detect chronic recreational drug use during pregnancy. In 2007, 347 mother-infant dyads were included from the Hospital La Candelaria, Santa Cruz de Tenerife, Canary Islands (Spain). Data on socioeconomic characteristics and on substance misuse during pregnancy were collected using a structured questionnaire. Drugs of abuse: opiates, cocaine, cannabinoids and amphetamines were detected in maternal hair by immunoassay followed by gas chromatography-mass spectrometry for confirmation and quantitation.

Results: Hair analysis revealed 2.6% positivity for cocaine and its metabolites. Use of cocaine during pregnancy was associated with unusual behaviour with potentially harmful effects on the baby.

Conclusions: The results of the study demonstrate significant cocaine use by pregnant women in Canary Islands. The data should be used for the purpose of preventive health and policy strategies aimed to detect and possibly to avoid in the future prenatal exposure to drugs of abuse.

Citing Articles

Toxicology as a diagnostic tool to identify the misuse of drugs in the perinatal period.

Jones J Front Pediatr. 2023; 10:1071564.

PMID: 36843886 PMC: 9944414. DOI: 10.3389/fped.2022.1071564.


Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants.

Jarque P, Roca A, Gomila I, Marchei E, Tittarelli R, Elorza M Biology (Basel). 2021; 10(4).

PMID: 33916618 PMC: 8067052. DOI: 10.3390/biology10040296.


Prevalence of prenatal exposure to substances of abuse: questionnaire versus biomarkers.

Chiandetti A, Hernandez G, Mercadal-Hally M, Alvarez A, Andreu-Fernandez V, Navarro-Tapia E Reprod Health. 2017; 14(1):137.

PMID: 29070078 PMC: 5657059. DOI: 10.1186/s12978-017-0385-3.

References
1.
Nakahara Y, Ochiai T, Kikura R . Hair analysis for drugs of abuse. V. The facility in incorporation of cocaine into hair over its major metabolites, benzoylecgonine and ecgonine methyl ester. Arch Toxicol. 1992; 66(6):446-9. DOI: 10.1007/BF02035137. View

2.
Maugh 2nd T . Hair: a diagnostic tool to complement blood serum and urine. Science. 1978; 202(4374):1271-3. DOI: 10.1126/science.725602. View

3.
Meeker J, Reynolds P . Fetal and newborn death associated with maternal cocaine use. J Anal Toxicol. 1990; 14(6):379-82. DOI: 10.1093/jat/14.6.379. View

4.
Williamson S, Jackson L, Skeoch C, Azzim G, Anderson R . Determination of the prevalence of drug misuse by meconium analysis. Arch Dis Child Fetal Neonatal Ed. 2006; 91(4):F291-2. PMC: 2672735. DOI: 10.1136/adc.2005.078642. View

5.
Joya X, Papaseit E, Civit E, Pellegrini M, Vall O, Garcia-Algar O . Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis. Ther Drug Monit. 2009; 31(3):391-5. DOI: 10.1097/FTD.0b013e31819c3f2b. View